Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Fuji
Deloitte
Baxter
Farmers Insurance
Covington
QuintilesIMS
Dow
Moodys

Generated: December 13, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DUVELISIB

« Back to Dashboard

Clinical Trials for Duvelisib

Trial ID Title Status Sponsor Phase Summary
NCT01476657 A Phase 1 Study of Duvelisib in Patients With Advanced Hematologic Malignancies Active, not recruiting Infinity Pharmaceuticals, Inc. Phase 1 The purpose of this study is to determine the safety, maximum tolerated dose and pharmacokinetics of IPI-145 in patients with advanced hematologic malignancies.
NCT01653756 A Phase 2a, Efficacy and Safety Study of Duvelisib in Mild Asthmatic Subjects Completed Infinity Pharmaceuticals, Inc. Phase 2 The purpose of this study is to examine the effects of multi-dose regimens of IPI-145 on lung function in mild asthmatic subjects following allergen challenge.
NCT01851707 A Double-Blind Study Evaluating Duvelisib in Subjects With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone Completed Infinity Pharmaceuticals, Inc. Phase 2 The purpose of this study is to investigate the safety and efficacy of multiple dose levels of the investigational product (study drug), IPI-145, in combination with methotrexate compared to methotrexate alone in subjects with active moderate-to-severe Rheumatoid Arthritis.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Duvelisib

Condition Name

Condition Name for Duvelisib
Intervention Trials
Chronic Lymphocytic Leukemia 5
Lymphoma 4
Small Lymphocytic Lymphoma 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Duvelisib
Intervention Trials
Lymphoma 11
Leukemia, Lymphocytic, Chronic, B-Cell 7
Leukemia, Lymphoid 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Duvelisib

Trials by Country

Trials by Country for Duvelisib
Location Trials
United States 82
Mexico 8
United Kingdom 5
Italy 5
Belgium 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Duvelisib
Location Trials
New York 8
Florida 8
Tennessee 7
Massachusetts 6
California 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Duvelisib

Clinical Trial Phase

Clinical Trial Phase for Duvelisib
Clinical Trial Phase Trials
Phase 3 4
Phase 2 5
Phase 1/Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Duvelisib
Clinical Trial Phase Trials
Active, not recruiting 6
Completed 5
Recruiting 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Duvelisib

Sponsor Name

Sponsor Name for Duvelisib
Sponsor Trials
Infinity Pharmaceuticals, Inc. 17
Dana-Farber Cancer Institute 2
AbbVie 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Duvelisib
Sponsor Trials
Industry 20
Other 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Express Scripts
Fish and Richardson
UBS
AstraZeneca
Deloitte
Citi
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.